MedTrace Logo

Special Drug Use Investigation for PAXIL Tablet (Long-term)

NCT01371448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 339

Last updated 2017-06-08

No results posted yet for this study

Summary

This surveillance study is designed to detect adverse events (particularly clinically significant adverse drug reactions) occurring in clinical settings and to examine factors likely to affect the safety and efficacy of paroxetine in long-term use (1 year).

Conditions

  • Mental Disorders

Interventions

DRUG

Paroxetine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31
Primary Completion
2004-09-30
Completion
2005-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01371448 on ClinicalTrials.gov